CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY - News), a leading RNAi therapeutics company, today reported its consolidated financial results for the third quarter of 2007, company highlights, and an update on pipeline goals and financial guidance.
